“Zoledr0nic Acid May Enhance the Doxorubicin Cytotoxicity Effect in Osteosarcoma Cell Line” (2022) Journal of Pharmaceutical Negative Results, 13(4), pp. 310–316. doi:10.47750/pnr.2022.13.04.037.